Area of research
Oncology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Virus-based gene therapy research, and CAR-T cell therapy research.
The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma
Transcriptome Profiling Identifies TIGIT as a Marker of T‐Cell Exhaustion in Liver Cancer
Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro
CD4 and CD8 T lymphocyte interplay in controlling tumor growth
Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer
CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations
Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells
Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer
Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
Oncolytic Viruses as Anticancer Vaccines
Genetic Predisposition and Environmental Danger Signals Initiate Chronic Autoimmune Hepatitis Driven by CD4+ T Cells